Variant report

Variant	nsv527294
Chromosome Location	chr9:118067966-118068722
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C9orf91-5	chr9:118068185-118068275	NONHSAT134411
2	lnc-C9orf91-5	chr9:118068185-118068275	NONHSAT134410

Extended variants
information (count: 27 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:27 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs13290457	chr9:118067966-118067967	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs570857550	chr9:118067968-118067969	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs555543992	chr9:118067970-118067971	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs550816798	chr9:118067973-118067974	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs561258153	chr9:118067984-118067985	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs530283918	chr9:118068001-118068002	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs79573223	chr9:118068006-118068007	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs567080533	chr9:118068035-118068036	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs538337294	chr9:118068051-118068052	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs186981687	chr9:118068081-118068082	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs574062689	chr9:118068088-118068089	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs568864318	chr9:118068102-118068103	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs537843086	chr9:118068138-118068139	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs368620398	chr9:118068176-118068177	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs374441469	chr9:118068203-118068204	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
16	rs554862234	chr9:118068266-118068267	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
17	rs75825293	chr9:118068269-118068270	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
18	rs533960977	chr9:118068324-118068325	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs375731895	chr9:118068437-118068438	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs553670920	chr9:118068447-118068448	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs372456214	chr9:118068501-118068502	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs554402211	chr9:118068512-118068513	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs376596896	chr9:118068519-118068520	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs577008401	chr9:118068545-118068546	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs192723238	chr9:118068668-118068669	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs75798220	chr9:118068683-118068684	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs1157836	chr9:118068722-118068723	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
lymphocytic leukemia	21291569	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	17603634	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	18632612	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Gastric cancer	17908304	CNVD
small cell lung cancer	20016488	CNVD
Cardiac fibroma	18329553	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
Lung cancer	19147751	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Melanoma	18172304	CNVD
Colorectal cancer	16272173	CNVD
Bladder cancer	21909424	CNVD
Breast cancer	21509527	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Cervical cancer	16585170	CNVD
Ependymoma	19289631	CNVD
Schizophrenia	18940311	CNVD
Neuroticism	17667963	CNVD
Cervical cancer	17311676	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Neurodevelopmental disorder	0	CNVD
Amyotrophic lateral sclerosis	20685689	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:10 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:118060000-118073200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
2	chr9:118067200-118068400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
3	chr9:118067400-118068200	Enhancers	Breast Myoepithelial Primary Cells	Breast
4	chr9:118067400-118068200	Flanking Active TSS	NHEK	skin
5	chr9:118067400-118068400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
6	chr9:118067400-118068400	Enhancers	HMEC	breast
7	chr9:118067400-118068600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
8	chr9:118068000-118068400	Enhancers	HUES6 Cell Line	embryonic stem cell
9	chr9:118068200-118068600	Enhancers	NHEK	skin
10	chr9:118068400-118071600	Weak transcription	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links